Case Reports in Oncology : Impact Factor & More
eISSN: 1662-6575pISSN: 1662-6575
Open AccessShare this on:
Key Metrics
CiteScore 
1.3
SJR
Q3Oncology
SNIP
0.59
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Case Reports in Oncology
Case Reports in Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Tri-annual |
| Article Processing Charges | EUR 1060 | USD 1230 | CHF 1100 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Tri-annual |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Case Reports in Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Case Reports in Oncology
Retraction Statement
- 31 Jul 2026
- Case Reports in Oncology
Case reports of four patients with HPV-positive head and neck cancer of non-oropharyngeal origin undergoing liquid biopsy for circulating cell-free HPV-DNA before, during and after treatment
- 21 Jul 2026
- Case Reports in Oncology
Primary Unknown Squamous Cell Carcinoma with the Anaplastic Lymphoma Kinase Fusion Gene That Was Effectively Treated with Alectinib: A Case Report
- 8 Jul 2026
- Case Reports in Oncology
Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab \u2013 A Case Report
- 30 Jun 2026
- Case Reports in Oncology
Safety and Efficacy of Enfortumab Vedotin and Pembrolizumab in 2 Hemodialysis Patients with Metastatic Urothelial Carcinoma: A Case Series
- 30 Jun 2026
- Case Reports in Oncology
Complete Response to Pembrolizumab in Radiation-Induced Undifferentiated Pleomorphic Sarcoma of the Face: A Case Report and Review of the Literature
- 30 Jun 2026
- Case Reports in Oncology
Retraction Statement
- 31 Jul 2026
- Case Reports in Oncology
Case reports of four patients with HPV-positive head and neck cancer of non-oropharyngeal origin undergoing liquid biopsy for circulating cell-free HPV-DNA before, during and after treatment
- 21 Jul 2026
- Case Reports in Oncology
Primary Unknown Squamous Cell Carcinoma with the Anaplastic Lymphoma Kinase Fusion Gene That Was Effectively Treated with Alectinib: A Case Report
- 8 Jul 2026
- Case Reports in Oncology
Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab \u2013 A Case Report
- 30 Jun 2026
- Case Reports in Oncology
Safety and Efficacy of Enfortumab Vedotin and Pembrolizumab in 2 Hemodialysis Patients with Metastatic Urothelial Carcinoma: A Case Series
- 30 Jun 2026
- Case Reports in Oncology
Complete Response to Pembrolizumab in Radiation-Induced Undifferentiated Pleomorphic Sarcoma of the Face: A Case Report and Review of the Literature
- 30 Jun 2026
- Case Reports in Oncology
FAQs on Case Reports in Oncology
How long has Case Reports in Oncology been actively publishing? 
What is the publishing frequency of Case Reports in Oncology?
How many articles did Case Reports in Oncology publish last year?
What is the eISSN & pISSN for Case Reports in Oncology?
What is Citescore for Case Reports in Oncology?
What is SNIP score for Case Reports in Oncology?
What is the SJR for Case Reports in Oncology?
Who is the publisher of Case Reports in Oncology?
